Medical Examination and Clinical Diagnosis

Comparison of the diagnostic value of serum IL⁃6, IL⁃8, TREM1, uPAR and presepsin in patients with septic shock

  • E LI ,
  • Wuhan HONG ,
  • Zhenxian WANG ,
  • Rong CHEN
Expand
  • Department of Critical Care Medicine,Haikou Hospital of Traditional Chinese Medicine,Haikou 570216,Hainan,China

Received date: 2025-06-13

  Online published: 2025-09-25

Abstract

Objective To observe the dynamic changes in serum levels of IL-6, IL-8, TREM-1, uPAR, and presepsin in patients with septic shock and to analyze the diagnostic significance of these biomarkers. Methods A total of 150 sepsis patients admitted to the hospital between February 2023 and February 2025 were prospectively enrolled as study subjects. According to their clinical conditions, the participants were categorized into a sepsis group (non-shock, n = 44) and a septic shock group (n = 106). Additionally, 30 healthy individuals with normal clinical indicators during the same period were selected as the control group. The serum levels of IL-6, IL-8, TREM-1, uPAR, and presepsin were measured and compared across the different groups. Spearman correlation analysis and logistic regression analysis were conducted to assess the association between these biomarkers and the severity of sepsis. The diagnostic performance of these biomarkers for septic shock was evaluated using receiver operating characteristic (ROC) curve analysis. Results There were statistically significant differences in serum levels of IL-6, IL-8, TREM1, uPAR, and presepsin among the different groups (P < 0.05), with the highest values observed in the septic shock group, followed by the sepsis group and the control group (P < 0.05). The APACHE Ⅱ and SOFA scores of patients with septic shock were significantly higher than those of patients with sepsis (P < 0.05). Spearman correlation analysis revealed that serum concentrations of IL-6, IL-8, TREM1, uPAR, and presepsin were positively correlated with both APACHE Ⅱ and SOFA scores, with correlation coefficients (rs) of 0.758, 0.880, 0.837, 0.832, and 0.846 for APACHE Ⅱ score, and 0.487, 0.549, 0.557, 0.626, and 0.664 for SOFA score, respectively (P < 0.05). Logistic regression analysis indicated that serum levels of IL-6 (OR = 1.055), IL-8 (OR = 1.054), TREM1 (OR = 1.038), uPAR (OR = 1.010), and presepsin (OR = 2.103) were significantly associated with the development of septic shock (P < 0.05). ROC curve analysis demonstrated that the AUC values for serum IL-6, IL-8, TREM1, uPAR, and presepsin in diagnosing septic shock were 0.608, 0.724, 0.887, 0.848, and 0.885, with corresponding sensitivities of 0.432, 0.909, 0.795, 0.909, and 0.591, and specificities of 0.880, 0.481, 0.915, 0.736, and 0.977, respectively. When these biomarkers were combined, the AUC increased to 0.973, with a sensitivity of 0.943 and a specificity of 0.953. Furthermore, the AUC for presepsin alone was significantly higher than that for IL-6 and IL-8 alone (P < 0.05). Additionally, the AUC for the combined biomarkers was significantly greater than that for each biomarker individually (P < 0.05). Conclusions Serum levels of IL-6, IL-8, TREM1, uPAR, and presepsin are significantly elevated in patients with septic shock, which may aid in the clinical diagnosis of the condition. The combined use of these five biomarkers enhances the accuracy of diagnosing septic shock.

Cite this article

E LI , Wuhan HONG , Zhenxian WANG , Rong CHEN . Comparison of the diagnostic value of serum IL⁃6, IL⁃8, TREM1, uPAR and presepsin in patients with septic shock[J]. The Journal of Practical Medicine, 2025 , 41(18) : 2937 -2944 . DOI: 10.3969/j.issn.1006-5725.2025.18.022

References

[1] 付晶, 张瑞鹏, 许美馨, 等. 中国西南地区某大型三甲综合医院脓毒症住院患者的流行病学分析[J]. 中华危重病急救医学, 2024, 36(6):574-577.
[2] CHIU C, LEGRAND M. Epidemiology of sepsis and septic shock[J]. Curr Opin Anaesthesiol, 2021, 34(2): 71-76. doi:10.1097/aco.0000000000000958
[3] FORD J S, MORRISON J C, KYAW M, et al. The Effect of Severe Sepsis and Septic Shock Management Bundle (SEP-1) Compliance and Implementation on Mortality Among Patients With Sepsis: A Systematic Review[J]. Ann Intern Med, 2025, 178(4): 543-557. doi:10.7326/annals-24-02426
[4] DESPOSITO L, BASCARA C. Review: Sepsis guidelines and core measure bundles[J]. Postgrad Med, 2024, 136(7): 702-711. doi:10.1080/00325481.2024.2388021
[5] 王丽娜,王华成,张一彤,等.血清IL-6对脓毒症病情判断的作用[J].中国热带医学,2018,18(8):827-829.
[6] THEOBALD V, SCHMITT F C F, MIDDEL C S, et al. Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies[J]. Crit Care, 2024, 28(1): 17. doi:10.1186/s13054-024-04798-2
[7] LIANG J, CAI Y, SHAO Y. Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: A systematic review and meta-analysis[J]. BMC Infect Dis, 2023, 23(1): 288. doi:10.1186/s12879-023-08262-4
[8] LIU Y C, YAO Y, YU M M, et al. Frequency and mortality of sepsis and septic shock in China: A systematic review and meta-analysis[J]. BMC Infect Dis, 2022, 22(1): 564. doi:10.1186/s12879-022-07543-8
[9] 冯珂, 勾燚, 吕博辉, 等. 严重创伤患者发生脓毒症的危险因素分析[J]. 中华创伤杂志, 2024, 40(8): 727-733.
[10] 丁一凡, 李晓青, 李雪珠, 等. 脓毒症集束化治疗对患者预后的影响及其实施现状[J]. 中华医学杂志, 2025, 105(11): 820-826.
[11] SARTINI C, LANDONI G, BELLETTI A, et al. Beyond the Surviving Sepsis Campaign Guidelines: A systematic review of interventions affecting mortality in sepsis[J]. Panminerva Med, 2024, 66(1): 55-62. doi:10.23736/s0031-0808.23.04986-8
[12] HUA T, YAO F, WANG H, et al. Megakaryocyte in sepsis: The trinity of coagulation, inflammation and immunity[J]. Crit Care, 2024, 28(1): 442. doi:10.1186/s13054-024-05221-6
[13] NEDEVA C. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis[J]. Biomolecules, 2021, 11(7): 1011. doi:10.3390/biom11071011
[14] ZANDERS L, KNY M, HAHN A, et al. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting[J]. J Cachexia Sarcopenia Muscle, 2022, 13(1): 713-727. doi:10.1002/jcsm.12867
[15] HAN T, LIANG T, LIU R, et al. The association between interleukin-8 gene polymorphism and the risk of sepsis in older adults[J]. J Orthop Surg Res, 2024, 19(1): 804. doi:10.1186/s13018-024-05296-5
[16] BARICHELLO T, GENEROSO J S, SINGER M, et al. Biomarkers for sepsis: More than just fever and leukocytosis-a narrative review[J]. Crit Care, 2022, 26(1): 14. doi:10.1186/s13054-021-03862-5
[17] YAJNIK V, MAAROUF R. Sepsis and the microcirculation: The impact on outcomes[J]. Curr Opin Anaesthesiol, 2022, 35(2): 230-235. doi:10.1097/aco.0000000000001098
[18] TORRES L K, PICKKERS P, VAN DER POLL T. Sepsis-Induced Immunosuppression[J]. Annu Rev Physiol, 2022, 84: 157-181. doi:10.1146/annurev-physiol-061121-040214
[19] CóRNEO E D S, MICHELS M, DAL-PIZZOL F. Sepsis, immunosuppression and the role of epigenetic mechanisms[J]. Expert Rev Clin Immunol, 2021, 17(2): 169-176. doi:10.1080/1744666x.2021.1875820
[20] 吴健锋. 脓毒症免疫抑制的监测和治疗进展[J]. 中山大学学报(医学版),2020,41(1):30-36.
[21] 王亚南, 王梦晴, 任云飞, 等. 脓毒症免疫抑制细胞的变化及其与预后关系的研究进展[J]. 中华急诊医学杂志, 2025, 34(2): 264-271.
[22] HAMADA M, VARKOLY K S, RIYADH O, et al. Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator[J]. Biomedicines, 2024, 12(6): 1167. doi:10.3390/biomedicines12061167
[23] NUSSHAG C, WEI C, HAHM E, et al. suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury[J]. JCI Insight, 2023, 8(7): e165740. doi:10.1172/jci.insight.165740
[24] NUSSHAG C, WEI C, HAHM E, et al. suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury[J]. JCI Insight, 2023, 8(7): e165740. doi:10.1172/jci.insight.165740
[25] NARENDRA S, WYAWAHARE M, ADOLE P S. Presepsin vs. Procalcitonin as Predictors of Sepsis Outcome[J]. J Assoc Physicians India, 2022, 70(11): 11-12. doi:10.5005/japi-11001-0146
[26] BAIK S M, PARK J, KIM T Y, et al. Validation of presepsin measurement for mortality prediction of sepsis: A preliminary study[J]. Acute Crit Care, 2022, 37(4): 527-532. doi:10.4266/acc.2022.00150
[27] LEE G B, LEE J W, YOON S H, et al. Plasma presepsin for mortality prediction in patients with sepsis-associated acute kidney injury requiring continuous kidney replacement therapy[J]. Kidney Res Clin Pract, 2024, 43(4): 457-468. doi:10.23876/j.krcp.23.301
[28] 李晶,陆芹芹,崔艳飞. 血清PGC-1α水平在脓毒症致急性肾损伤诊断中的价值[J]. 实用医学杂志, 2023, 39(4):471-475. doi:10.3969/j.issn.1006-5725.2023.04.015
[29] 吴海燕,王宝玉,贾宝辉. 外周血游离线粒体DNA,miR-146a表达对评估脓毒症患者近期预后的价值[J]. 实用医学杂志, 2024, 40(23):3356-3361.
Outlines

/